2014
DOI: 10.3892/ol.2014.2377
|View full text |Cite
|
Sign up to set email alerts
|

Rare incidence of a diffuse brain metastatic carcinoma: A case report

Abstract: Brain metastases generally present in the parenchyma of the brain. In the current report, a very rare case of brain metastasis, which simultaneously invaded the subgaleal region, the skull, and the dural and cavernous sinuses is presented. The patient, a 54-year-old female, complained of a progressive headache and exhibited the symptoms of intracranial hypertension. Coronal contrast-enhanced T1-weighted magnetic resonance imaging (MRI) showed high intensity signals in the subgaleal tissue of the left frontopar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…However, for a long time, none of these methods was assigned as the standard therapy in clinical practice. The median survival time of affected patients is 1-3 months without therapy (1). The median survival time increases to ~6 months after WBRT (2) and to 10 months subsequent to using the Gamma Knife radiosurgery (GKRS) method (3).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, for a long time, none of these methods was assigned as the standard therapy in clinical practice. The median survival time of affected patients is 1-3 months without therapy (1). The median survival time increases to ~6 months after WBRT (2) and to 10 months subsequent to using the Gamma Knife radiosurgery (GKRS) method (3).…”
Section: Introductionmentioning
confidence: 99%
“…Three methods, including stereotactic radiosurgery, general surgery and whole-brain radiation therapy (WBRT), are normally clinically used and are relatively effective for treating brain metastases (1). However, for a long time, none of these methods was assigned as the standard therapy in clinical practice.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation